Antibody recognition of the type 14 pneumococcal capsule. Evidence for a conformational epitope in a neutral polysaccharide.
about
Recombinant expression of Streptococcus pneumoniae capsular polysaccharides in Escherichia coli.Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgGLiposomal co-entrapment of CD40mAb induces enhanced IgG responses against bacterial polysaccharide and proteinPneumococcal capsular polysaccharide structure predicts serotype prevalenceInfections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyStreptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes.Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?Transient hydrogen bonding in uniformly ¹³C,¹⁵N-labeled carbohydrates in water.Functional capacities of clonal antibodies to Haemophilus influenzae type b polysaccharide.Identification of pneumococcal colonization determinants in the stringent response pathway facilitated by genomic diversity.Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugatesDifferential idiotype utilization for the in vivo type 14 capsular polysaccharide-specific Ig responses to intact Streptococcus pneumoniae versus a pneumococcal conjugate vaccinePreparation and immunogenicity of gold glyco-nanoparticles as antipneumococcal vaccine model.Current status of meningococcal group B vaccine candidates: capsular or noncapsular?Identification of a genetic locus essential for capsule sialylation in type III group B streptococci.Purification and characterization of Streptococcus adjacens (nutritionally variant Streptococcus serotype II) group antigen.Relation between structure and immunologic properties of the Vi capsular polysaccharide.Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.Carbohydrate targets in HIV vaccine research: lessons from failures.Antibody recognition of carbohydrate epitopes†.Epitope specificities of the group Y and W-135 polysaccharides of Neisseria meningitidis.Distinct pattern of antibody reactivity with oligomeric or polymeric forms of the capsular polysaccharide of Haemophilus influenzae type b.NMR studies of carbohydrates and carbohydrate-mimetic peptides recognized by an anti-group B Streptococcus antibody.Thermodynamics and density of binding of a panel of antibodies to high-molecular-weight capsular polysaccharidesRecognition of bacterial capsular polysaccharides and lipopolysaccharides by the macrophage mannose receptor.Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.Neoglycoconjugate of Tetrasaccharide Representing One Repeating Unit of the Streptococcus pneumoniae Type 14 Capsular Polysaccharide Induces the Production of Opsonizing IgG1 Antibodies and Possesses the Highest Protective Activity As Compared to HeStructural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta.After chemotherapy, functional humoral response capacity is restored before complete restoration of lymphoid compartments
P2860
Q27336832-05CED3D0-17CC-44B3-BD3D-82E5F68D89E4Q28367535-756FFC23-E023-45CA-B339-2DA4EBC83478Q28472828-DFD28627-B0CC-47D2-A40E-197311A385EBQ28475595-38D225DA-C35C-4423-839A-25A9C51864B5Q28972389-962AC5B6-7A4F-4F27-84BB-172677FE350AQ33754233-1CBD6DC2-6834-4A0B-A50E-8507A2E300F1Q33998397-2F820282-6FE9-4D64-BBF8-70633DEC76ECQ34000276-BFC7AE24-96FB-4B4C-B9A2-36BF3A89DE48Q35428480-9F2DEF9D-3CC2-48AC-ACCA-586190DFC16CQ35585053-9A45E115-5831-47C8-8651-924919138A6CQ35596498-4F125711-159F-4F79-A8E0-7D2DDA783791Q36084183-762E7A74-6E4C-494C-8890-CCE57A90D2ECQ36202229-B69150FB-58BC-43A3-B3A5-BFE8D84A7818Q36642138-5943C02C-0856-493D-BD03-30AA1BCD4C39Q36957482-50F2F61F-1E69-49AF-BAE5-C164FD2CBBB1Q36961542-4554EE2C-F63C-4DCF-92B8-BB3179BD7107Q36990350-B43D7F75-99AF-497A-B27A-F43EBC679527Q37361495-B19FCD7E-5BFD-47F6-A71E-B733257DD1EDQ37773298-F2ED721B-BD10-400B-BCC5-81843C7F8E09Q37840398-13915318-DE8B-48C0-A458-891EC6356AFEQ38298541-22732FF3-2254-46D5-BA3D-C76FB766AB0CQ38332084-E1BE5373-7C24-4C57-B9C2-63D5D116A8C3Q38355497-22D66F5B-0760-4056-AC95-3B9DA7E1E737Q38359065-C61B58F5-4975-4B73-8B6A-EE5C782EC1BDQ38363532-6320605A-0CC4-4704-9CF2-029DE8B11CFCQ40056277-030C3B1D-DBF7-4399-ABB6-11E3DB597399Q40167840-EEBAF4EA-848B-4080-A55F-F29C81016045Q47871941-61384AB0-845C-4974-B4C8-07020D8025CAQ57892192-D5A4750D-1992-44A5-ACBD-C7401F6CC1CC
P2860
Antibody recognition of the type 14 pneumococcal capsule. Evidence for a conformational epitope in a neutral polysaccharide.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Antibody recognition of the ty ...... e in a neutral polysaccharide.
@ast
Antibody recognition of the ty ...... e in a neutral polysaccharide.
@en
type
label
Antibody recognition of the ty ...... e in a neutral polysaccharide.
@ast
Antibody recognition of the ty ...... e in a neutral polysaccharide.
@en
prefLabel
Antibody recognition of the ty ...... e in a neutral polysaccharide.
@ast
Antibody recognition of the ty ...... e in a neutral polysaccharide.
@en
P2860
P356
P1476
Antibody recognition of the ty ...... e in a neutral polysaccharide.
@en
P2093
D L Kasper
M R Wessels
P2860
P304
P356
10.1084/JEM.169.6.2121
P407
P577
1989-06-01T00:00:00Z